Qtron Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Qtron Investments's GILD Position: Q2 2026 in Review
Qtron Investments reduced its Gilead Sciences (GILD) stake by 28% in Q2 2026, selling an estimated $636K and leaving 12,413 shares worth $1.57M. The position accounts for 0.21% of the portfolio, ranked #86.
Qtron Investments first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.4M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Qtron Investments held 12,413 shares of Gilead Sciences worth $1.57M as of Q2 2026.
- Qtron Investments sold 4,828 Gilead Sciences shares in Q2 2026, an estimated $636K.
- Gilead Sciences made up 0.21% of Qtron Investments's portfolio in Q2 2026, its #86 holding.
- Qtron Investments first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
- Qtron Investments's Gilead Sciences position peaked at $2.4M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.